These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7230954)

  • 1. [Value of the use of a new hepatotropic drug, arginine tidiacicate in gastroenterology. Results of a multicentric study].
    Raymond N
    Med Chir Dig; 1981; 10(2):181-4. PubMed ID: 7230954
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic action of arginine-thiazolidine-carboxylate (ATCA) as evaluated by liver function tests].
    Alvisĭ V; D'Ambrosi A; Lo Ponte A; Tampieri ML; Tralli M
    Arch Sci Med (Torino); 1980; 137(4):731-8. PubMed ID: 7018458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of tiadilon in hepatobiliary pathology].
    Saigot T
    Med Chir Dig; 1979; 8(6):575-6. PubMed ID: 529858
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of administration of arginine thiazolidinecarboxylate in liver pathology of various origins. Results of a multicenter study].
    Gasbarrini G; Bernardi M
    Minerva Dietol Gastroenterol; 1982; 28(2):143-52. PubMed ID: 7099448
    [No Abstract]   [Full Text] [Related]  

  • 5. [Controlled clinical study of the therapeutic activity of arginine thiazolidine carboxylate in patients with chronic toxic and postinfective hepatopathies].
    Salsano F; Ciancarelli MP
    Minerva Dietol Gastroenterol; 1979; 25(4):391-8. PubMed ID: 400006
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hepatoprotective drugs. Clinical results of the use of a sulfhydryl-methylating preparation].
    Rapino P; Marulli R; Rapex G; Della Lunga S; Sabatino P
    Minerva Med; 1982 Oct; 73(40):2853-60. PubMed ID: 7133498
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical experimentation with a new hepatotropic agent, EU 2200].
    Linquette M; Decoulx M
    Lille Med; 1966 Nov; 11(9):1051-5. PubMed ID: 5994072
    [No Abstract]   [Full Text] [Related]  

  • 8. [Arginine thiazolidinecarboxylate in hepatology. Preliminary report].
    Calabrese L; Zoni R
    Minerva Dietol Gastroenterol; 1980; 26(1):51-7. PubMed ID: 7374998
    [No Abstract]   [Full Text] [Related]  

  • 9. [The therapeutic value of anabolic steroids in gastroenterology].
    Demole M
    Schweiz Med Wochenschr; 1966 Mar; 96(9):291-6. PubMed ID: 5983996
    [No Abstract]   [Full Text] [Related]  

  • 10. [Further clinical observations on the treatment of noncirrhotic alcoholic liver disease].
    Buzzi S; Ghetti C; Sala G
    Ateneo Parmense Acta Biomed; 1980; 51(3):139-45. PubMed ID: 7213456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experiment comparative clinical study with three liver trophical substances on some alcoholic not cirrhotic liver disease (author's transl)].
    Buzzi S; Ghetti C; Sala G
    Ateneo Parmense Acta Biomed; 1980; 51(3):129-37. PubMed ID: 7213455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Action of thiazolidine carboxylic acid in hepatic pathology].
    Dornier R
    Therapeutique; 1968 Nov; 44(9):555-7. PubMed ID: 5759648
    [No Abstract]   [Full Text] [Related]  

  • 13. [Further clinical research on the antitoxin and hepatoprotective action of arginine glucose-1-phosphate].
    Barbieri D; Parravicini M
    Clin Ter; 1966 Feb; 36(3):191-208. PubMed ID: 5935211
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the treatment of various liver diseases by oral administration of arginine glucose-1-phosphate].
    Arrigo A
    Clin Ter; 1967 Dec; 43(6):523-41. PubMed ID: 5617980
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic study of thiazolidine carboxylic acid in liver diseases].
    Carneiro Filho DA; Brandão ED
    Hospital (Rio J); 1969 Apr; 75(4):1187-96. PubMed ID: 5306413
    [No Abstract]   [Full Text] [Related]  

  • 16. [Controlled clinical trial of arginine malate associated with cytidine and uridine in secondary hepatopathies].
    Rampazzo F
    Minerva Med; 1974 Feb; 65(15):838-49. PubMed ID: 4826131
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experience with a new hepatoprotector].
    Rocca F
    Clin Ter; 1969 Jun; 49(5):473-8. PubMed ID: 5386746
    [No Abstract]   [Full Text] [Related]  

  • 18. [Significance of combined arginine-betaine-sorbitol therapy in the treatment of metabolic liver diseases].
    Abbou R; Mahoudeau D; Dubrisay J; Volteau M
    Sem Hop; 1965 Apr; 41(19):1170-6. PubMed ID: 4284191
    [No Abstract]   [Full Text] [Related]  

  • 19. [Beta-blockers in gastroenterology and hepatology].
    Malè PJ
    Rev Med Suisse Romande; 1984 Mar; 104(3):203-6. PubMed ID: 6144157
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of therapeutic activity of a new pharmacologic combination in patients with chronic liver and debilitating diseases].
    Pasotti C; Buniva G; Carpinella G
    Clin Ter; 1971 Mar; 56(5):427-39. PubMed ID: 5564990
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.